India to United States: Vaccine Export Trade Route
India has recorded 94 verified shipments of Vaccine exported to United States, representing a combined trade value of $40.6M USD. This corridor is served by 11 active Indian exporters, with an average shipment value of $431.5K USD. The leading Indian exporter is SERUM INSTITUTE OF INDIA PRIVATE LIMITED, which accounts for 100% of total export value with 51 shipments worth $40.5M USD. On the buying side, XXRUMXXIFEXXCIEXXES XXD is the largest importer in United States with $14.3M USD in purchases. The top 3 suppliers — SERUM INSTITUTE OF INDIA PRIVATE LIMITED, KALINDI OVERSEAS, ATLAS ENTERPRISES — together control 100% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Vaccine corridor is one of India's established pharmaceutical export routes, with 94 shipments documented worth a combined $40.6M USD. The route is dominated by SERUM INSTITUTE OF INDIA PRIVATE LIMITED, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's vaccine manufacturing sector.
Across 11 active suppliers, the average shipment value stands at $431.5K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 85% of all shipments, consistent with vaccine's non-urgent bulk-order profile.
Shipment activity peaks during January–March, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 15.1%, placing it at rank #9 among India's top vaccine export destinations globally.
On the import side, key buyers of Indian vaccine in United States include XXRUMXXIFEXXCIEXXES XXD, SERUM LIFE SCIENCES LIMITED, SERUM LIFE SCIENCES LTD and 34 others. XXRUMXXIFEXXCIEXXES XXD is the single largest importer with 8 shipments valued at $14.3M USD.
Route Characteristics
- Average transit33 days
- Peak seasonQ1
- Primary modeSea freight
- Top portSez Bio Tech Services
Market Position
- Global rank#9
- Annual growth+15.1%
- Demand growth+15.0%
- Regulatory ease90/100
Top 10 Indian Vaccine Exporters to United States
Showing top 10 of 11 Indian suppliers exporting Vaccine to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | SERUM INSTITUTE OF INDIA PRIVATE LIMITED Avg $794.5K per shipment | 51 | $40.5M | 99.9% |
| 2 | KALINDI OVERSEAS Avg $9.7K per shipment | 4 | $38.9K | 0.1% |
| 3 | ATLAS ENTERPRISES Avg $576 per shipment | 5 | $2.9K | 0.0% |
| 4 | EXQUISITE PHARMA Avg $251 per shipment | 6 | $1.5K | 0.0% |
| 5 | ZYDUS LIFESCIENCES LIMITED Avg $80 per shipment | 2 | $160 | 0.0% |
| 6 | SHARVIK IMPEX (INDIA) PRIVATE LIMITED Avg $146 per shipment | 1 | $146 | 0.0% |
| 7 | CADILA HEALTHCARE LIMITED Avg $96 per shipment | 1 | $96 | 0.0% |
| 8 | RUCHA ENTERPRISES Avg $3 per shipment | 18 | $54 | 0.0% |
| 9 | BHARAT BIOTECH INTERNATIONAL LIMITED Avg $7 per shipment | 1 | $7 | 0.0% |
| 10 | GENNOVA BIOPHARMACEUTICALS LIMITED Avg $1 per shipment | 3 | $2 | 0.0% |
This table shows the top 10 of 11 Indian companies exporting vaccine to United States, ranked by total trade value. The listed exporters are: SERUM INSTITUTE OF INDIA PRIVATE LIMITED, KALINDI OVERSEAS, ATLAS ENTERPRISES, EXQUISITE PHARMA, ZYDUS LIFESCIENCES LIMITED, SHARVIK IMPEX (INDIA) PRIVATE LIMITED, CADILA HEALTHCARE LIMITED, RUCHA ENTERPRISES, BHARAT BIOTECH INTERNATIONAL LIMITED, GENNOVA BIOPHARMACEUTICALS LIMITED. SERUM INSTITUTE OF INDIA PRIVATE LIMITED is the dominant supplier with 51 shipments worth $40.5M USD, giving it a 100% market share. The top 3 suppliers together account for 100% of the total trade value on this route.
Showing top 10 of 11 total Indian exporters on the India to United States Vaccine export route.
Top 10 Vaccine Importers in United States
Showing top 10 of 37 known buyers in United States receiving Vaccine shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian vaccine in United States include XXRUMXXIFEXXCIEXXES XXD, SERUM LIFE SCIENCES LIMITED, SERUM LIFE SCIENCES LTD, THE PURCHASE DEPARTMENT, UNIVERSAL MARINE MEDICAL SUPPLY INT, among 37 total buyers. The largest importer is XXRUMXXIFEXXCIEXXES XXD, accounting for $14.3M USD across 8 shipments — representing 35% of all vaccine imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | XXRUMXXIFEXXCIEXXES XXD | 8 | $14.3M | 35.3% |
| 2 | SERUM LIFE SCIENCES LIMITED | 8 | $14.3M | 35.3% |
| 3 | SERUM LIFE SCIENCES LTD | 10 | $11.9M | 29.2% |
| 4 | THE PURCHASE DEPARTMENT | 3 | $24.5K | 0.1% |
| 5 | UNIVERSAL MARINE MEDICAL SUPPLY INT | 1 | $14.4K | 0.0% |
| 6 | XXBRAXXI | 1 | $5.2K | 0.0% |
| 7 | DABRAZZI | 1 | $5.2K | 0.0% |
| 8 | VERONICA HERNANDEZ | 4 | $2.8K | 0.0% |
| 9 | NOVAVAX INC | 9 | $2.2K | 0.0% |
| 10 | CRYSTAL HELEN MEADOWS | 6 | $1.5K | 0.0% |
Showing top 10 of 37 Vaccine importers in United States on this route.
Top 10 Vaccine Formulations Imported by United States
Showing top 10 of 42 product formulations shipped on the India to United States Vaccine route, ranked by trade value
United States imports a wide range of vaccine formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — NUVAXOVID (COVID-19 VACCINE) — accounts for $12.0M USD across 6 shipments. There are 42 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | NUVAXOVID (COVID-19 VACCINE) | 6 | $12.0M | 29.5% |
| 2 | NUVAXOVID COVID-19 VACCINE | 6 | $11.9M | 29.5% |
| 3 | NUVAXOVID COVID-19 VACCINE | 7 | $8.3M | 20.4% |
| 4 | NUVAXOVID COVID-19 VACCINE | 5 | $6.0M | 14.7% |
| 5 | NUVAXOVID (COVID-19 VACCINE ) | 2 | $2.4M | 5.8% |
| 6 | YELLOW FEVER VACCINE (LIVE) I.P.(BRAND:STAMARIL )NOS | 1 | $14.4K | 0.0% |
| 7 | YELLOW FEVER VACCINE LIVE I.P.BRAND:STAMARIL | 1 | $13.5K | 0.0% |
| 8 | YELLOW FEVER VACCINE LIVE I.P. | 1 | $10.4K | 0.0% |
| 9 | NUVAVAX (COVID 19 VACCINE ) NANOPARTICLE | 4 | $6.2K | 0.0% |
| 10 | NUVAVAX COVID 19 VACCINE NANOPARTICLE | 4 | $6.2K | 0.0% |
Showing top 10 of 42 Vaccine formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 85%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
Sez Bio Tech Services handles the highest volume with 18 shipments. Transit time averages 33 days by sea.
Market Dynamics
India's vaccine exports to United States are driven primarily by a handful of large-scale manufacturers. SERUM INSTITUTE OF INDIA PRIVATE LIMITED with 51 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 11 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — SERUM INSTITUTE OF INDIA PRIVATE LIMITED, KALINDI OVERSEAS, ATLAS ENTERPRISES — together account for 100% of total trade value on this route. The average shipment value of $431.5K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as nuvaxovid covid-19 vaccine and nuvaxovid covid-19 vaccine , suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, XXRUMXXIFEXXCIEXXES XXD is the largest importer with 8 shipments worth $14.3M USD — representing 35% of all vaccine imports from India on this route. A total of 37 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $40.6M
- Avg. Shipment
- $431.5K
- Suppliers
- 11
- Buyers
- 37
- Transit (Sea)
- ~33 days
- Annual Growth
- +15.1%
Reverse Direction
United States → India — Vaccine (Import)Other Vaccine Routes
Unlock the Full India to United States Vaccine Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 94 shipments on this route.
Frequently Asked Questions — India to United States Vaccine Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Vaccine to United States?
The leading Indian exporters of Vaccine to United States are SERUM INSTITUTE OF INDIA PRIVATE LIMITED, KALINDI OVERSEAS, ATLAS ENTERPRISES. SERUM INSTITUTE OF INDIA PRIVATE LIMITED holds the largest market share at approximately 100% of total trade value on this route.
Q What is the total value of Vaccine exports from India to United States?
India exports Vaccine to United States worth approximately $40.6M USD across 94 recorded shipments. The average value per shipment is $431.5K USD.
Q Which ports does India use to ship Vaccine to United States?
The most active port of origin is Sez Bio Tech Services with 18 shipments. Indian exporters primarily use sea freight for this route, with 85% of shipments going by sea and 30% by air.
Q How long does shipping take from India to United States for Vaccine?
The average transit time for Vaccine shipments from India to United States is approximately 33 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during January–March.
Q Is the India to United States Vaccine trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 15.1% with demand growth tracking at 15.0%. The route is ranked #9 among India's top Vaccine export destinations globally.
Q How many suppliers are active on the India to United States Vaccine route?
There are currently 11 active Indian suppliers exporting Vaccine to United States. The market is moderately concentrated with SERUM INSTITUTE OF INDIA PRIVATE LIMITED accounting for 100% of total shipment value.
Q Who are the main importers of Vaccine from India in United States?
The leading importers of Indian Vaccine in United States include XXRUMXXIFEXXCIEXXES XXD, SERUM LIFE SCIENCES LIMITED, SERUM LIFE SCIENCES LTD, THE PURCHASE DEPARTMENT, UNIVERSAL MARINE MEDICAL SUPPLY INT. XXRUMXXIFEXXCIEXXES XXD is the largest buyer with 8 shipments worth $14.3M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Vaccine.
- 2.Supplier/Buyer Matching: 11 Indian exporters and 37 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 94 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
94 Verified Shipments
11 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists